News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
ReNeuron Reports Encouraging Signs From Parkinson’s Disease Programme
February 16, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ReNeuron Group PLC said the stem cells it is working on to find a treatment for Parkinson's disease have shown attributes that could be used to reverse the effects of the illness.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Europe
MORE ON THIS TOPIC
Immunology and inflammation
Takeda’s $4B Nimbus Bet Pays Off With ‘Best-in-Class’ Phase III Plaque Psoriasis Data
December 19, 2025
·
2 min read
·
Tristan Manalac
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
December 18, 2025
·
1 min read
·
BioSpace Insights
Obesity
Lilly’s Obesity Pill Maintains Weight Loss as Estimated Approval Timelines Inch Closer
December 18, 2025
·
2 min read
·
Tristan Manalac
Autoimmune disease
Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg
December 17, 2025
·
2 min read
·
Tristan Manalac
